Novartis receives FDA approval for Rhapsido® , the only oral, targeted BTKi treatment for chronic spontaneous urticaria
Nine Mile Metals Announces Completion of DDH WD-26-01, Intersecting 129.72 Meters of Visual Mineralization and Identifies Two Massive Sulphide Zones
Metalsource Mining Continues to Expand High Grade Corridor at Silver Hill with Successful Step Out Drilling
